Systemic Lupus Erythematosus (SLE) is an autoimmune disease that affects many parts of the body. Currently available treatments have helped many people with SLE. but for some, these treatments don’t work well enough or have side effects associated with them.
Clinical Research Philadelphia is now enrolling participants for an SLE study. Please fill out the questionnaire to schedule a qualification call today.
The study will assess if taking the investigational drug alongside a standard SLE regimen (known as ‘standard of care’) is an effective and safe treatment for people who:
Have active SLE
- Are aged between 18 and 75 years old (inclusive)
- Must be taking at least one SLE treatment (e.g. Hydroxychloroquine)
Study DetailsParticipants who qualify may receive:
- Study-related Medication, exams & lab work at no cost
- Compensation for time and travel may also be available
Please fill out the form